Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab

BACKGROUND: Currently, there are no known effective treatments for recurrent glioblastoma once patients have progressed on a bevacizumab-containing regimen. We examined the efficacy of adding nitrosoureas to bevacizumab in patients who progressed while on an initial bevacizumab-containing regimen. M...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rahman, Rifaquat, Hempfling, Kelly, Norden, Andrew D., Reardon, David A., Nayak, Lakshmi, Rinne, Mikael L., Beroukhim, Rameen, Doherty, Lisa, Ruland, Sandra, Rai, Arun, Rifenburg, Jennifer, LaFrankie, Debra, Alexander, Brian M., Huang, Raymond Y., Wen, Patrick Y., Lee, Eudocia Q.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2014
Предметы:
Clinical Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201074/
https://ncbi.nlm.nih.gov/pubmed/24958095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou118
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы